RecruitingNot ApplicableNCT05367609

Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)


Sponsor

Senthil Sadhasivam

Enrollment

300 participants

Start Date

Sep 20, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this collaborative CTSA application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in children undergoing painful surgery.


Eligibility

Min Age: 10 YearsMax Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Preoperative Genotyping for people with ppap and spine fusion. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 10 Years to 21 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTPreoperative Genotyping

Genotype based risk prediction and personalized pain management


Locations(5)

University of California

San Francisco, California, United States

Children's Orthopaedic and Scoliosis Surgery Associates, LLP

St. Petersburg, Florida, United States

Johns Hopkins All Children's Hospital

St. Petersburg, Florida, United States

Riley Children's Hospital

Indianapolis, Indiana, United States

UPMC Children's Hospital

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05367609


Related Trials